Skip to main content

2018 Phillies Prospects Countdown: #6 OF Jhailyn Ortiz

Jhailyn Ortiz, image- MiLB.com
The Phillies signed outfielder Jhailyn Ortiz at the age of 16 for a reported $4 million.  Teams don't make that sort of investment or shell out the largest signing bonus for an international player in organization history without a boat load of high hopes.  It seems the talented youngster is well on his way to living up to those expectations.

The powerful Dominican Republic native made his regular season pro debut as a member of the Rookie level Gulf Coast League Phillies in 2016.  In 47 games there, Ortiz batted .231 with eight home runs, 27 RBI and eight stolen bases.

In 2017 Ortiz was with the short-season Class A Williamsport Crosscutters.  He sported a .302 batting average with 15 doubles, a triple, eight homers and 30 RBI in 47 contests.  Having turned 19 years old in November, he was among the youngest players in the New York-Penn League last year.  His .961 OPS would have been good enough to lead the league if he has notched enough plate appearances to qualify.

Ortiz, a righty batter, features boast-worthy power with plus potential. He can knock the ball out of any park he plays in and has the ability to hit to all fields.  He took strides toward becoming a more complete hitter, as was evidenced by the 71-point jump in his average from the previous campaign.  He makes excellent contact, barrelling up the ball in all areas of the strike zone.

Last season, working on plate discipline was key for Ortiz, as the Phils want to see him reduce his strike outs. At roughly a 26% strike out rate in the minors, he has a lot of work ahead to improve in that aspect.

On top of all the offensive praise, he also is a quality defender with a strong arm.  He has played strictly right field in the minors to date.

As a base runner, Ortiz likely will not be a regular stolen base threat, but he is quick-footed enough that he won't be a detriment to his club.

Listed at six-feet-three and 215 pounds, Ortiz is a strapping young man and could add even more strength as he progresses in the professional ranks.

Coaches think Ortiz is a special talent with a very bright future.  He'll likely be in the middle of the lineup for the Class A Lakewood BlueClaws for much of this coming season.


You can keep track of this year's Phillies prospect countdown at this link.

Comments

Popular posts from this blog

What the hell else was I going to write about...?

It will be too late for many people's liking, but it's really about time to NEVER USE BRAD LIDGE IN A SAVE SITUATION ON THE ROAD AGAIN. Lidge in 2009 road games- 0-6, 8.10 ERA, 15 saves, 10 blown saves. One of my favorite statistics that I regularly update here on PhoulBallz is the percentage of games that Brad Lidge has allowed earned runs in this season, compared to the 18% he allowed in 2008. This year, Lidge has allowed earned runs in 43% of his outings. And, as a reminder, in 2007 Brett Myers allowed earned runs in just 21% of his relief appearances. Considering Lidge's season-long struggles, what is the solution when Brett Myers is ailing with a back muscle/shoulder injury, when Chan Ho Park has an injured hamstring, when Ryan Madson looks just as inept in the 9th inning as Brad Lidge seems and when JC Romero is still unavailable to pitch due to a forearm injury? Well, on Wednesday night, with Hanley Ramirez batting with two outs and the tying run on 3rd base, your an...

More headline entertainment

CBS3.com has enlightened the Phillies world to the genius that is new GM Ruben Amaro Jr. In the steal of the century, the Phils have apparently signed outfielder Jayson Werth to a $10 contract. Wow! If you catch this soon enough the headline blunder is still there, but if not, here's a screen capture of the dealio.

Romero Settlement "Validates" Phils' Title

Back in 2008, Phillies lefty reliever J.C. Romero tested positive for banned substances and was subsequently suspended for the first 50 games of the 2009 season. Some felt the findings in Romero's test tainted the World Series victory by Philadelphia that year. Romero contested that he had only used supplements purchased at local vitamin chains and the companies responsible for those items should be held accountable for mislabeling their products. Romero took his issues to court, filing lawsuits in New Jersey Superior Court in early 2009 that named GNC and Vitamin Shoppe as defendants in addition to the manufacturing companies, Ergopharm and Proviant Technologies. According to the NY Daily News , testing done on the vitamins revealed that they were tainted with the banned substance, androstenedione, that Romero tested positive for. This month, nearly three years later, Romero has reached a settlement, which Romero hopes will clear his name and provide closure for Philadelphia...